Purified anti-human GM-CSF Maxpar Ready Antibody anti-GM-CSF - BVD2-21C11,BioLegend,502315

Additional reported applications (for the relevant formats) include: ELISA1-4or ELISPOT3,4Detection, Neutralization1, immunohistochemical staining of paraformaldehyde-fixed, saponin-treated5,6and acetone-fixed7frozen tissue sections, and immunocytochemistry.Note:For testing human GM-CSF in serum or plasma, BioLegend's ELISA Max™ Sets (Cat. No. 432001 to 432006) are specially developed and recommended.

Host

Rat

Reactivity

Human

Application

ELISA Capture -Quality testedCyTOF® -Verified

Platform ID

BAB149928673

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-human GM-CSF Maxpar Ready Antibody anti-GM-CSF - BVD2-21C11
Cat. No.502315
HostRat
RRIDAB_2563770 (BioLegend Cat. No. 502315)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationELISA Capture -Quality testedCyTOF® -Verified
ClonalityMonoclonal
Clone NumberBVD2-21C11
Concentration1.0 mg/ml
TargetGM-CSF
ImmunogenE. coli-expressed, recombinant human GM-CSF.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Granulocyte/macrophage - colony stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T cells, B cells, mast cells, macrophages, fibroblasts, and endothelial cells. In addition to supporting colony formation of granulocyte/macrophage progenitors, GM-CSF is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.